Working… Menu

Phase 3 Safety and Efficacy Study of ART-123 in Subjects With Severe Sepsis and Coagulopathy

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT01598831
Recruitment Status : Completed
First Posted : May 15, 2012
Last Update Posted : June 19, 2019
Information provided by (Responsible Party):
Asahi Kasei Pharma America Corporation